MEMBRANE DYNAMICS AND FUNCTIONAL EFFECTS ON MYELOMA CELLS AFTER DARATUMUMAB TREATMENT

被引：0
作者：
Yakymiv, Y. [1 ]
Faini, A. C. [1 ]
Castella, B. [1 ]
Morandi, F. [1 ]
Larocca, A. [1 ]
Oliva, S. [1 ]
Horenstein, A. L. [1 ]
Massaia, M. [1 ]
Malavasi, F. [1 ]
机构：
[1] Dipartimento Sci Med, Lab Immunogenet, Turin, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO095
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
[41]   Daratumumab in combination in multiple myeloma in relapse: after Castor, here is Pollux! [J].
Philippe, Laure .
Hematologie, 2016, 22 (06) :380-381
[42]   Progressive multifocal leukoencephalopathy after daratumumab in multiple myeloma: A case report [J].
Caracciolo, Nicoletta Giuseppa ;
Di Clemente, Laura ;
Galizia, Pierluigi ;
La Cesa, Silvia ;
Prosperini, Luca ;
Cozzolino, Valeria ;
Gasperini, Claudio ;
Tortorella, Carla .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 :60-61
[43]   Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma [J].
Nakagawa, Ryo ;
Onishi, Yasushi ;
Kawajiri, Akihisa ;
Onodera, Koichi ;
Furukawa, Eijiro ;
Sano, Sayaka ;
Saito, Kei ;
Ichikawa, Satoshi ;
Fujiwara, Tohru ;
Fukuhara, Noriko ;
Harigae, Hideo .
ANNALS OF HEMATOLOGY, 2019, 98 (08) :1999-2001
[44]   Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma [J].
Ryo Nakagawa ;
Yasushi Onishi ;
Akihisa Kawajiri ;
Koichi Onodera ;
Eijiro Furukawa ;
Sayaka Sano ;
Kei Saito ;
Satoshi Ichikawa ;
Tohru Fujiwara ;
Noriko Fukuhara ;
Hideo Harigae .
Annals of Hematology, 2019, 98 :1999-2001
[45]   Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment [J].
Kosei Matsue ;
Kazutaka Sunami ;
Morio Matsumoto ;
Junya Kuroda ;
Isamu Sugiura ;
Hiromi Iwasaki ;
Weiyuan Chung ;
Shigeki Kuwayama ;
Mitsufumi Nishio ;
Kim Lee ;
Shinsuke Iida .
International Journal of Hematology, 2022, 116 :122-130
[46]   EFFECTS OF AMIODARONE ON LIPID DYNAMICS IN ERYTHROCYTE-MEMBRANE INVITRO AND AFTER CHRONIC TREATMENT [J].
CHATELAIN, P ;
BROTELLE, R ;
LARUEL, R .
ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1985, 276 (02) :327-328
[47]   Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment [J].
Matsue, Kosei ;
Sunami, Kazutaka ;
Matsumoto, Morio ;
Kuroda, Junya ;
Sugiura, Isamu ;
Iwasaki, Hiromi ;
Chung, Weiyuan ;
Kuwayama, Shigeki ;
Nishio, Mitsufumi ;
Lee, Kim ;
Iida, Shinsuke .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (01) :122-130
[48]   Successful treatment of scleromyxedema with daratumumab, lenalidomide and dexamethasone in a patient with multiple myeloma [J].
Bettolini, Luca ;
Bighetti, Stefano ;
Maione, Vincenzo ;
Ghini, Iacopo ;
Segala, Diego ;
Calzavara-Pinton, Piergiacomo .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (04) :e104-e107
[49]   Daratumumab for the Treatment of Multiple Myeloma: A Review of Clinical Applicability and Operational Considerations [J].
Arnall, Justin R. ;
Maples, Kathryn T. ;
Harvey, R. Donald ;
Moore, Donald C. .
ANNALS OF PHARMACOTHERAPY, 2022, 56 (08) :927-940
[50]   SUBCUTANEOUS DARATUMUMAB IN THE TREATMENT OF MULTIPLE MYELOMA IN ITALY: A BUDGET IMPACT ANALYSIS [J].
Ghetti, G. ;
Pradelli, L. ;
Crovato, E. ;
Bellucci, S. .
VALUE IN HEALTH, 2022, 25 (01) :S74-S74
12345